Trials / Completed
CompletedNCT04122222
Immune Response to Influenza Vaccine in ESRD Patients
Immune Response to Influenza Vaccination in ESRD Patients Undergoing Hemodialysis vs. Hemodiafiltration
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
On-line hemodiafiltration (HDF) clears more azotaemic toxins compared to high-flux hemodialysis (HD). The response to vaccination is impaired in dialysis patients. We aimed to study the immune responses to influenza vaccine in dialysis patients treated by HDF vs. HD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Influenza vaccine | A single standard dose of inactivated trivalent influenza vaccine: Influvac® vaccines (Abbott, the Netherlands), intramuscularly. |
Timeline
- Start date
- 2016-08-25
- Primary completion
- 2018-07-20
- Completion
- 2018-07-20
- First posted
- 2019-10-10
- Last updated
- 2019-10-10
Source: ClinicalTrials.gov record NCT04122222. Inclusion in this directory is not an endorsement.